Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

Clinical trial NCT06703593 · COMPLETED

Trial details

NCT number: NCT06703593
Sponsor: British University In Egypt
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Female

Start date: 2023-10-01
Primary completion: 2025-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.